Latest immunotherapy Stories

2015-05-29 16:25:07

ImmunoSelect-R Combines Industry-Leading Accuracy of PGDx's CancerXome(TM) Whole Exome Analysis and Its Predictive Bioinformatics to Guide Selection of Tumor Antigen Therapeutic Targets and Stratify

2015-05-29 08:28:38

Companies Also Plan to Initiate Phase 3 Trial in Combination for Advanced Melanoma THOUSAND OAKS, Calif.

2015-05-28 16:32:45

SOUTH SAN FRANCISCO, Calif., May 28, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced that Sean McCarthy,

2015-05-28 08:31:20

Updated Survival Data and New Report from Prospective Cohort Suggest Benefits of Sequencing Proleukin Before Targeted Therapies CHICAGO, May 28, 2015 /PRNewswire/ -- Prometheus

2015-05-28 08:31:15

Data Demonstrates Extension of Survival of Metastatic Melanoma Patients Treated with Proleukin Followed by Immune Checkpoint Blockade of the Programmed Death (PD-1/PD-L1) Pathway CHICAGO,

2015-05-28 08:29:44

NORTH BRUNSWICK, N.J., May 28, 2015 /PRNewswire/ -- PDS Biotechnology Corp.

2015-05-26 23:05:34

A new study suggests that having cytoreductive surgery can make immunotherapy more effective for patients with advanced mesothelioma. Raleigh, NC (PRWEB) May

2015-05-26 16:28:35

Plasma Cell Disorders, Epidemiology Studies Also Play a Prominent Role NEW YORK, May 26, 2015 /PRNewswire-USNewswire/ -- NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer

2015-05-26 16:28:24

Talimogene Laherparepvec First Oncolytic Immunotherapy to Demonstrate Therapeutic Benefit for Patients With Advanced Melanoma THOUSAND OAKS, Calif., May 26, 2015 /PRNewswire/ --

Word of the Day
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).